Cancer Immunotherapy Month: June 2024 Join the global fight against cancer! Unite for Cancer Immunotherapy Month Join us in June for Cancer Immunotherapy Month™, where we will educate the public about immunotherapy, raise awareness, and fuel vital fundraising efforts in the fight against cancer. At the Cancer Research Institute (CRI), we proudly fund innovative research that helps foster a global community dedicated to creating a world immune to cancer. Throughout Cancer Immunotherapy Month™, you have the chance to directly support groundbreaking research and unlock new immunotherapy breakthroughs to confront cancer head-on and improve lives. While you can give all month long, there’s no better day to make a difference than June 14, #Immune2Cancer Day. Your donation will be matched up to $300,000 by a group of generous donors only until June 30, 2024. Join us as we build a community, celebrate scientific discoveries, and bring people together. Donate Now to help create a world immune to cancer. Fund a Future Immune to Cancer Donate today, and your donation will be matched up to $300,000 by a group of generous donors only until June 30, 2024. Donate Now June 2024 – Events & Happenings Stay tuned in June when our Immunotherapy Month Calendar goes live. Be sure to check back each week to catch all of the exciting happenings we have lined up as we celebrate advancements in cancer research. June 2023 M T W T F S S 29 30 31 1Cancer Immunotherapy Month Begins!2#CrushCancer with #StreamCRI!3Where Innovation Lives4Timeline of Discovery5Rising Female Talents in Cancer Immunotherapy Research6Connecting People, Biology, and Data7Accelerating Life-Saving Discoveries8Immunotherapy Minute9Fueling Discovery1070th Anniversary Playlist11Together, we can #CrushCancer!12The Next Wave of Discoveries13The Countdown to #Immune2Cancer Day Begins!14Two Days Until #Immune2Cancer Day!15Tomorrow is #Immune2Cancer Day!16#Immune2Cancer Day17Accelerating Discovery18LaToya’s Patient Story19A Community of Researchers20The CRISPR Revolution: How Genomic Engineering is Transforming Cancer Immunotherapy21A Future #Immune2Cancer22TBT: #Immune2Cancer Day!23Dr. Vonderheide on Treating Pancreatic Cancer: ‘CRI Has Been There From the Start’24Your content, your way, all dedicated to a great cause.25Join Us In A New Era of Hope and Discovery26New Immunotherapies Bring Hope to Patients with Rare Liver Cancers27Immunotherapy Minute: Circulating Tumor DNA with CRI Clinical Investigator Dr. Elsa Anagnostou28Creating a Future #Immune2Cancer29How Breakthroughs in Immunotherapy are Helping Non-Small Cell Lung Cancer Patients Live Longer30Thank you! 1 2 What is Cancer Immunotherapy Month? Celebrated every June, Cancer Immunotherapy Month was created by CRI following the landmark FDA approval of the first checkpoint inhibitor in 2011. This annual observance is dedicated to raising awareness, educating the public about immunotherapy, and reflecting on the transformative potential and significant advancements in cancer immunotherapy. The creation of Cancer Immunotherapy Month marks CRI’s commitment to funding pioneering research that propels the field forward. By spotlighting the progress achieved and emphasizing the ongoing need for research, education, and funding, CRI continues to lead the charge toward future innovations with the ultimate goal of creating a world immune to cancer. Engage and Learn: Events and Webinars June offers a variety of educational opportunities, including CRI-hosted events and webinars. These are designed to share knowledge, inspire, and provide insights into the future of immunotherapy. Engage with leading experts to deepen your understanding and stay informed about the latest advances in immunotherapy. Discover the groundbreaking work of CRI-funded scientists pushing the frontiers of immunotherapy. Their research ranges from enhancing T-cell responses to developing novel vaccines that prime the immune system to fight cancer. CRI’s Immunotherapy Month calendar allows you to track events, engage with content, ask questions, and deepen your understanding of the current landscape and future direction of cancer immunotherapy. Key Success Stories Over the past eleven years, Cancer Immunotherapy Month has marked the evolution of immunotherapy from a niche research area to a mainstay in the treatment of over twenty types of cancer. Among these inspiring narratives are those of Emily Whitehead, the first child successfully treated with CAR T cell therapy; Sharon Belvin, who overcame stage 4 melanoma with the aid of checkpoint blockade immunotherapy; and Rikki Rockett, the drummer for Poison, who found a new lease on life through a clinical trial after traditional treatments failed him. These stories exemplify the transformative power of immunotherapy, turning once insurmountable odds into a success story. CRI continues to be at the forefront of this endeavor, supporting research that has not only paved the way for FDA-approved therapies but also ignited a global movement to embrace immunotherapy as a viable treatment option. Gratitude and Partnership We extend our deepest gratitude to the dedicated scientists, sponsors, partners, donors, patients, caregivers, and community members who support CRI’s mission. Your contributions are pivotal in advancing the field of immunotherapy and bringing us closer to a world immune to cancer. Together, we are making significant strides in cancer research, patient support, and global impact. Your partnership is vital to our shared journey. A Unified Fight Against Cancer Discover the endless possibilities of cancer immunotherapy with CRI during Cancer Immunotherapy Month. Our commitment to groundbreaking immunotherapy research, unwavering support for patients, and relentless pursuit of innovative treatments define our mission. Cancer Immunotherapy Month is a time to celebrate progress and discovery while shining a spotlight on the potential of immunotherapy for all types of cancer. CRI accomplishes this by: Hosting webinars that spotlight the latest advancements and trends in immunotherapy treatments for patients. Presents our featured series, “I’M the Answer to Cancer™,” which showcases powerful patient stories that highlight the promise of immunotherapy and serve as a guide to inform others about how to access these new treatments. Shares personal accounts from patients detailing their cancer experiences and the transformative role immunotherapy played in their healing and recovery. Join us in shaping the future of cancer—because every breakthrough today is a lifeline for tomorrow. Your support fuels hope, accelerates discoveries, and transforms lives. Together, let’s create a world immune to cancer through the power of immunotherapy. Donate Now to Help Fund Cancer Research and Bring More Hope to Patients Get Social Follow us on social media, and post your own content, using the hashtag #Immune2Cancer Facebook Instagram X LinkedIn Related Links CRI Timeline of Discovery Immunotherapy at a Glance 2023 Impact Report 70 Years of Discovery Ways to Give Donate Now Stay up to date Get the latest cancer immunotherapy updates. Subscribe to the CRI email newsletter. Name: Field Is Required First Field Is Required Last Email: Field Is Required Email: Spam Control Text: Please leave this field empty